Market Overview

Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

116.91 +1.91 (1.66%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2021
After-Hours
EPS:
REV:
0.97
258.5M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
0.82
237.1M



Q4 2020
After-Hours
EPS:
REV:
1.05
244.1M



Q3 2020
After-Hours
EPS:
REV:
0.9
222.094M
0.22
283.04M
0.97
258.5M
340.91%
-8.67%
Q2 2020
After-Hours
EPS:
REV:
0.71
183.58M
0.73
260.34M
1.42
302.4M
94.52%
16.16%
Q1 2020
After-Hours
EPS:
REV:
-1.12
138.403M
0.54
223.87M
0.82
237.1M
51.85%
5.91%
Q4 2019
After-Hours
EPS:
REV:
0.19
131.492M
0.75
230.94M
1.05
244.1M
40%
5.7%
Q3 2019
After-Hours
EPS:
REV:
0.52
151.757M
0.64
211.63M
0.56
222.094M
-12.5%
4.94%
Q2 2019
After-Hours
EPS:
REV:
-0.07
96.905M
0.11
163.14M
0.32
183.58M
190.91%
12.53%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!